These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7755378)

  • 21. [Human papilloma virus and cervical cancer].
    Kawana T
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):615-9. PubMed ID: 2157368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological assays for the detection of HPV antibodies.
    Galloway DA
    IARC Sci Publ; 1992; (119):147-61. PubMed ID: 1330907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of papillomaviruses in the etiology of cervix cancer].
    von Knebel Doeberitz M
    Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):511-7. PubMed ID: 2167860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies.
    Baay MF; Duk JM; Groenier KH; Burger MP; de Bruijn HW; Hollema H; Stolz E; Herbrink P
    Cancer Immunol Immunother; 1997 Jun; 44(4):211-5. PubMed ID: 9222279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals.
    Luxton JC; Rowe AJ; Cridland JC; Coletart T; Wilson P; Shepherd PS
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1585-93. PubMed ID: 8758003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomaviruses and cervical carcinoma.
    Vousden KH
    Cancer Cells; 1989 Oct; 1(2):43-50. PubMed ID: 2561870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The frequency of papillomavirus infection in cervical precancerous lesions in Japan: an immunoperoxidase study.
    Nakajima T; Tsumuraya M; Morinaga S; Teshima S; Shimosato Y; Kishi K; Ohmi K; Sonoda T; Tsunematsu R; Tanemura K
    Jpn J Cancer Res; 1986 Sep; 77(9):891-5. PubMed ID: 3021698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transforming genes of human papillomaviruses and cancer].
    Hakura A
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1244-53. PubMed ID: 2164358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus (HPV) infections in the aetiology of cervical cancer.
    McCance DJ
    Cancer Surv; 1988; 7(3):499-506. PubMed ID: 2854000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of antibodies against human papillomavirus type 16 E4 and E7 proteins in sera of patients with cervical neoplasias.
    Stoian M; Repanovici R
    Rev Roum Virol; 1994; 45(3-4):185-92. PubMed ID: 7619739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia.
    Marais DJ; Best JM; Rose RC; Keating P; Soeters R; Denny L; Dehaeck CM; Nevin J; Kay P; Passmore JA; Williamson AL
    J Med Virol; 2001 Sep; 65(1):149-54. PubMed ID: 11505457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomaviruses.
    zur Hausen H; de Villiers EM
    Annu Rev Microbiol; 1994; 48():427-47. PubMed ID: 7826013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA.
    Pater MM; Hughes GA; Hyslop DE; Nakshatri H; Pater A
    Nature; 1988 Oct; 335(6193):832-5. PubMed ID: 2847052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.
    Onda T; Kanda T; Zanma S; Yasugi T; Watanabe S; Kawana T; Ueda K; Yoshikawa H; Taketani Y; Yoshiike K
    Int J Cancer; 1993 Jun; 54(4):624-8. PubMed ID: 8390409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomaviruses and other biological markers in cervical cancer.
    Shah KV
    IARC Sci Publ; 1992; (119):209-18. PubMed ID: 1330911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum antibody against unfused recombinant E7 protein of human papillomavirus type 16 in cervical cancer patients.
    Fujii T; Matsushima Y; Yajima M; Sugimura T; Terada M
    Jpn J Cancer Res; 1995 Jan; 86(1):28-34. PubMed ID: 7737906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of a new type of human papillomavirus (HPV52b) with a transforming activity from cervical cancer tissue.
    Yajima H; Noda T; de Villiers EM; Yajima A; Yamamoto K; Noda K; Ito Y
    Cancer Res; 1988 Dec; 48(24 Pt 1):7164-72. PubMed ID: 2847864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysplasia and HPV infection initially detected by DNA analysis in cytomorphologically normal cervical smears.
    Saito J; Sumiyoshi M; Nakatani H; Ikeda M; Hoshiai H; Noda K
    Int J Gynaecol Obstet; 1995 Oct; 51(1):43-8. PubMed ID: 8582517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions.
    Wideroff L; Schiffman M; Haderer P; Armstrong A; Greer CE; Manos MM; Burk RD; Scott DR; Sherman ME; Schiller JT; Hoover RN; Tarone RE; Kirnbauer R
    J Infect Dis; 1999 Nov; 180(5):1424-8. PubMed ID: 10515799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of human papillomavirus DNA without amplification: prospects for clinical utility.
    Lörincz A
    IARC Sci Publ; 1992; (119):135-45. PubMed ID: 1330906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.